RECRUITING

AYA OMGYES Sexual Health Study

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to assess the impact of the web-based intervention OMGYES.com on sexual dysfunction in young adult (YA) female-bodied cancer survivors. This pilot trial seeks to evaluate the intervention's: * feasibility * acceptability * appropriateness. Researchers will utilize an active observation period to compare outcomes between those receiving the intervention immediately and those who haven't Participants will: * Complete online modules at home * Visit the clinic every 5 weeks for questionnaires

Official Title

Assessing the Impact of a Web-based Educational Program on the Sexual Health Outcomes of Young Adult Female Cancer Survivors ~ A Pilot Trial

Quick Facts

Study Start:2025-01-16

Study Completion:2026-05-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06868121

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 40 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:No

Standard Ages:ADULT

Inclusion Criteria	Exclusion Criteria
* Age 18 to 40 years * Diagnosis of cancer between the ages of 15 and 40 * Female genitalia, regardless of gender * Diagnosed with sexual dysfunction * Complete Remission and at least two months from a major treatment * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial * Ability to participate in study modules and to respond to surveys * Ability to understand and the willingness to sign a written informed consent document	* Patients receiving other investigational agents * Patients expected to be neutropenic or have a significantly high infection risk that would exclude them from vaginal penetration * Patients who are unable complete the study intervention or surveys

Inclusion Criteria

Exclusion Criteria

* Age 18 to 40 years
* Diagnosis of cancer between the ages of 15 and 40
* Female genitalia, regardless of gender
* Diagnosed with sexual dysfunction
* Complete Remission and at least two months from a major treatment
* Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
* Ability to participate in study modules and to respond to surveys
* Ability to understand and the willingness to sign a written informed consent document

* Patients receiving other investigational agents
* Patients expected to be neutropenic or have a significantly high infection risk that would exclude them from vaginal penetration
* Patients who are unable complete the study intervention or surveys

Contacts and Locations

Study Contact

Cassandra Kuissi, BS

CONTACT

7737021220

cassandra.kuissi@bsd.uchicago.edu

Principal Investigator

Adam DuVall, MD

PRINCIPAL_INVESTIGATOR

University of Chicago

Study Locations (Sites)

University of Chicago Hospital

Chicago, Illinois, 60637

United States

Collaborators and Investigators

Sponsor: University of Chicago

Adam DuVall, MD, PRINCIPAL_INVESTIGATOR, University of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-16

Study Completion Date2026-05-01

Study Record Updates

Study Start Date2025-01-16

Study Completion Date2026-05-01

Terms related to this study

Additional Relevant MeSH Terms

Sexual Dysfunction